OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Nephrology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
A UMOD variant with intermediate effects	838
Making advance care planning easier for adults with kidney disease and their clinicians	722
Mentorship in the lives of scholars	482
Engineered CAR macrophages target kidney inflammation	476
Role of the gut microbiota in the pathogenesis of IgA nephropathy	436
The changing landscape of kidney health and disease in Africa	410
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	410
Kidney health within the broader non-communicable disease agenda	364
The GLP-1 receptor agonist revolution comes to nephrology	314
Disaster preparedness for patients with kidney disease	302
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	289
Vaccination in patients with kidney failure: lessons from COVID-19	239
Uropathogen and host responses in pyelonephritis	233
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	231
Treatment of chronic kidney disease in older populations	214
Designing acute kidney injury clinical trials	205
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	191
A single-cell atlas of DKD treatment responses	190
Genetic determinants of urine and plasma metabolite levels	175
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	173
The continued odyssey to unravel the secrets of kidney inflammation	171
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	168
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	164
Consideration of sex differences is necessary to achieve health equity	158
Beyond state borders: transforming dialysis care for undocumented immigrants	158

Roles of sensory receptors in non-sensory organs: the kidney and beyond	153
Phosphate sensing via PTC glycolysis	146
Complosome — the intracellular complement system	146
Mutational signatures of ccRCC vary between geographical regions	141
Bringing Pride to nephrology	140
20 years of Nature Reviews Nephrology	136
Reducing preventable acute kidney injury in a hospital setting	133
Informing clinical decision making during a pandemic — a call for better preparedness	133
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	130
The effects of sex hormone therapy on kidney function	117
Clonal haematopoiesis and AKI	113
Aquaporin water channels: roles beyond renal water handling	107
Menopause and chronic kidney disease	107
Interferon blockade in lupus: effects on antiviral immunity	106
Increasing diversity and inclusion in nephrology clinical trials	94
The roles of hyaluronan in kidney development, physiology and disease	94
Design of a renal-sparing antifungal	89
NUAK1 promotes kidney fibrosis	88
Treatment of SLE with anti-CD19 CAR-T cells	87
Benefits of actin cytoskeleton stabilization	85
Heat and health inequity: acting on determinants of health to promote heat justice	83
Identification of erythropoietin-producing cells	82
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	82
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	77
From fat to filter: the effect of adipose tissue-derived signals on kidney function	77
Tertiary lymphoid organs contribute to kidney allograft rejection	76
Long-term health outcomes associated with hydration status	76
Salt substitution: opportunities and challenges for nephrology	73
Pathological mechanisms of kidney disease in ageing	71
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	70
The role of complement in kidney disease	70
Reaping the rewards of mechanistic discovery in glomerular disease	69
Neutrophils and NETs in kidney disease	69
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	68
A golden year of innovative kidney disease therapeutics	67
The evolving landscape of immune-mediated glomerular diseases	67
A pathway of osmotic stress-induced necroptosis	67
MSC therapy for diabetic kidney disease and nephrotic syndrome	66
An integrated approach towards a public health perspective on chronic kidney disease	64